135 related articles for article (PubMed ID: 35997210)
1. Pilot proteomic study of locally advanced rectal cancer before and after neoadjuvant chemoradiotherapy indicates high metabolic activity in non-responders' tumor tissue.
Babic T; Lygirou V; Rosic J; Miladinov M; Rom AD; Baira E; Stroggilos R; Pappa E; Zoidakis J; Krivokapic Z; Nikolic A
Proteomics Clin Appl; 2023 Jan; 17(1):e2100116. PubMed ID: 35997210
[TBL] [Abstract][Full Text] [Related]
2. Identification of Predictive Markers for Response to Neoadjuvant Chemoradiation in Rectal Carcinomas by Proteomic Isotope Coded Protein Label (ICPL) Analysis.
Croner RS; Sevim M; Metodiev MV; Jo P; Ghadimi M; Schellerer V; Brunner M; Geppert C; Rau T; Stürzl M; Naschberger E; Matzel KE; Hohenberger W; Lottspeich F; Kellermann J
Int J Mol Sci; 2016 Feb; 17(2):209. PubMed ID: 26861291
[TBL] [Abstract][Full Text] [Related]
3. Identification of protein clusters predictive of tumor response in rectal cancer patients receiving neoadjuvant chemo-radiotherapy.
Repetto O; De Re V; De Paoli A; Belluco C; Alessandrini L; Canzonieri V; Cannizzaro R
Oncotarget; 2017 Apr; 8(17):28328-28341. PubMed ID: 28423701
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients.
Lopes-Ramos CM; Habr-Gama A; Quevedo Bde S; Felício NM; Bettoni F; Koyama FC; Asprino PF; Galante PA; Gama-Rodrigues J; Camargo AA; Perez RO; Parmigiani RB
BMC Med Genomics; 2014 Dec; 7():68. PubMed ID: 25496125
[TBL] [Abstract][Full Text] [Related]
5. Identification of proteins associated with treatment response of neoadjuvant chemoradiotherapy in rectal mucinous adenocarcinoma by co-expression network analysis based on proteomic analysis.
Sun Y; Lin Y; Deng Y; Wu X; Zhong J; Huang Y; Jiang W; Chi P
J Proteomics; 2022 Mar; 254():104472. PubMed ID: 34990823
[TBL] [Abstract][Full Text] [Related]
6. Predicting the pathological response to neoadjuvant chemoradiation using untargeted metabolomics in locally advanced rectal cancer.
Jia H; Shen X; Guan Y; Xu M; Tu J; Mo M; Xie L; Yuan J; Zhang Z; Cai S; Zhu J; Zhu Z
Radiother Oncol; 2018 Sep; 128(3):548-556. PubMed ID: 30041962
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy.
Wang H; Ji D; Tian H; Gao Z; Song C; Jia J; Cui X; Zhong L; Shen J; Gu J
BMC Cancer; 2022 Aug; 22(1):868. PubMed ID: 35945555
[TBL] [Abstract][Full Text] [Related]
8. Rectal Cancer Tissue Lipidome Differs According to Response to Neoadjuvant Therapy.
Sánchez-Vinces S; Duarte GHB; Messias MCF; Gatinoni CFA; Silva AAR; Sanches PHG; Martinez CAR; Porcari AM; Carvalho PO
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511236
[TBL] [Abstract][Full Text] [Related]
9. Do treated rectal tumors appear differently on MRI after chemotherapy versus chemoradiotherapy?
Shen Y; Wen Y; Bi L; Yang X; Gong X; Deng X; Meng W; Wang Z
Abdom Radiol (NY); 2024 Mar; 49(3):774-782. PubMed ID: 37999742
[TBL] [Abstract][Full Text] [Related]
10. Tumor microRNAs Identified by Small RNA Sequencing as Potential Response Predictors in Locally Advanced Rectal Cancer Patients Treated With Neoadjuvant Chemoradiotherapy.
Machackova T; Trachtova K; Prochazka V; Grolich T; Farkasova M; Fiala L; Sefr R; Kiss I; Skrovina M; Dosoudil M; Berindan-Neagoe I; Svoboda M; Slaby O; Kala Z
Cancer Genomics Proteomics; 2020; 17(3):249-257. PubMed ID: 32345666
[TBL] [Abstract][Full Text] [Related]
11. Molecular and Kinetic Analyses of Circulating Tumor Cells as Predictive Markers of Treatment Response in Locally Advanced Rectal Cancer Patients.
Troncarelli Flores BC; Souza E Silva V; Ali Abdallah E; Mello CAL; Gobo Silva ML; Gomes Mendes G; Camila Braun A; Aguiar Junior S; Thomé Domingos Chinen L
Cells; 2019 Jun; 8(7):. PubMed ID: 31247977
[TBL] [Abstract][Full Text] [Related]
12. FOSL2 promotes intertumoral infiltration of T cells and increases pathological complete response rates in locally advanced rectal cancer patients.
Xu K; Yin X; Zhou B; Zheng X; Wang H; Chen J; Cai X; Gao H; Xu X; Wang L; Shen L; Guo T; Zheng S; Li B; Shao Y; Wang J
Cancer Lett; 2023 May; 562():216145. PubMed ID: 36997107
[TBL] [Abstract][Full Text] [Related]
13. Identification of proteomic markers for prediction of the response to 5-Fluorouracil based neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.
Wang J; Liu J; Wang J; Wang S; Li F; Li R; Liu P; Li M; Wang C
Cancer Cell Int; 2022 Mar; 22(1):117. PubMed ID: 35292026
[TBL] [Abstract][Full Text] [Related]
14. ceRNA Networks: The Backbone Role in Neoadjuvant Chemoradiotherapy Resistance/Sensitivity of Locally Advanced Rectal Cancer.
He L; Chang H; Qi Y; Zhang B; Shao Q
Technol Cancer Res Treat; 2021; 20():15330338211062313. PubMed ID: 34908512
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
[No Abstract] [Full Text] [Related]
16. Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer.
Dayde D; Tanaka I; Jain R; Tai MC; Taguchi A
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28272347
[TBL] [Abstract][Full Text] [Related]
17. Data-Independent Acquisition Mass Spectrometry Analysis of FFPE Rectal Cancer Samples Offers In-Depth Proteomics Characterization of the Response to Neoadjuvant Chemoradiotherapy.
Stanojevic A; Samiotaki M; Lygirou V; Marinkovic M; Nikolic V; Stojanovic-Rundic S; Jankovic R; Vlahou A; Panayotou G; Fijneman RJA; Castellví-Bel S; Zoidakis J; Cavic M
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895091
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA expression profiles identify biomarkers for predicting the response to chemoradiotherapy in rectal cancer.
Du B; Wang X; Wu D; Wang T; Yang X; Wang J; Shi X; Chen L; Zhang W
Mol Med Rep; 2018 Aug; 18(2):1909-1916. PubMed ID: 29956755
[TBL] [Abstract][Full Text] [Related]
19. Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study.
Yi Y; Shen L; Shi W; Xia F; Zhang H; Wang Y; Zhang J; Wang Y; Sun X; Zhang Z; Zou W; Yang W; Zhang L; Zhu J; Goel A; Ma Y; Zhang Z
Clin Cancer Res; 2021 Mar; 27(5):1329-1340. PubMed ID: 33298472
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.
Svoboda M; Sana J; Fabian P; Kocakova I; Gombosova J; Nekvindova J; Radova L; Vyzula R; Slaby O
Radiat Oncol; 2012 Nov; 7():195. PubMed ID: 23167930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]